Citations 1
CLO26-104: TBCRC 050: A Phase 1b/2 Trial of Niraparib and Trastuzumab in HER2+ Metastatic Breast Cancer (MBC): Safety and Efficacy
Stringer-Reasor, Erica, Li, Yufeng , Zhang, Jianqing , Rocque, Gabrielle, Jones, Kyla R, O'Sullivan, C. C., Dees, Elizabeth Claire , Nanda, Rita, Hunter, Natasha, Clark, Amy S. , Wolff, Antonio, Krop, Ian E. , Lin, Nancy, Yang, Eddy S. , O'Sullivan, Ciara, Giridhar, Karthik, Stringer-Reasor, Erica , Rocque, Gabrielle B. , O’Sullivan, Ciara C. , Giridhar, Karthik V. , Hunter, Natasha B. , Wolff, Antonio C. , Rimawi, Mothaffar F.
Journal of the National Comprehensive Cancer Network | March 27, 2026 | Volume: 24 | Issue: 3.5 | Pages: No page available
